Hysteroscopic Dynamic Assessment of the Endometrium in Patients Treated with Long-Term Tamoxifen

Journal of Minimally Invasive Gynecology

Volumn 18, Issue 3, 2011, Pages 349-354

  Pérez Medina, Tirso ^a   Salazar, Francisco J ^b   San Frutos, Luis ^a   Ríos, Mar ^a   Jiménez, Jesús S ^c   Troyano, Juan ^e   Cayuela, Enrique ^d   Iglesias, Enrique ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d HOSPITAL GENERAL DE CATALUNYA   (Spain)

^e HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Diagnostic hysteroscopy; Endometrial changes; Tamoxifen

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CYST; ECHOGRAPHY; ENDOMETRIUM; ENDOMETRIUM ATROPHY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM POLYP; FEMALE; FOLLOW UP; HUMAN; HYSTEROSCOPY; LONG TERM CARE; MAJOR CLINICAL STUDY; PATHOGENESIS; SIDE EFFECT; VASCULARIZATION;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS, HORMONAL; ATROPHY; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; HYSTEROSCOPY; MIDDLE AGED; PROSPECTIVE STUDIES; TAMOXIFEN;

EID: 79955526461     PISSN: 15534650     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmig.2010.12.014     Document Type: Article

References (18)

1. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 1992, 339:71-85. Breast Cancer Trialist Collaborative Group.
2. Sendag F., Sahin C., Zeybek B., Terek M.C., Oztekin K., Bilgin O. Retrospective analysis of hysteroscopic findings in breast cancer patients having adjuvant tamoxifen treatment. Eur J Gynaecol Oncol 2010, 31:415-417.
3. van Leeuwen F.E., Benraadt J., Coebergh J.W., et al. Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 1994, 343:448-452.
4. Pérez-Medina T., López-Mora P., Rojo J., et al. Comparison of the hysteroscopy-biopsy with the D&C in the diagnosis of abnormal uterine bleeding. Prog Obstet Ginecol 1994, 37:479-486.
5. Burke C. Endometrial cancer and tamoxifen. Clin J Oncol Nurs 2005, 9:247-249.
6. Lindahl B., Andolf E., Ingvar C., Ranstam J., Willén R. Adjuvant tamoxifen in breast cancer patients affects the endometrium by time, an effect remaining years after end of treatment and results in an increased frequency of endometrial carcinoma. Anticancer Res 2008, 28:1259-1262.
7. Shi A.A., Lee S.I. Radiological reasoning: algorithmic workup of abnormal vaginal bleeding with endovaginal sonography and sonohysterography. Am J Roentgenol 2008, 191:68-73.
8. Karlsson B., Granberg S., Wikland M., et al. Transvaginal ultrasonography of endometrium in women with postmenopausal bleeding. A Nordic multicenter study. Am J Obstet Gynecol 1995, 173:1637-1648.
9. Giorda G., Crivellari D., Veronesi A., et al. Comparison of ultrasonography, hysteroscopy, and biopsy in the diagnosis of endometrial lesions in postmenopausal tamoxifen-treated patients. Acta Obstet Gynecol Scand 2002, 81:975-980.
10. Sendag F., Sahin C., Zeybek B., Terek M.C., Oztekin K., Bilgin O. Retrospective analysis of hysteroscopic findings in breast cancer patients having adjuvant tamoxifen treatment. Eur J Gynaecol Oncol 2010, 31:415-417.
11. Garuti G., Cellani F., Grossi F., Colonnelli M., Centinaio G., Luerti M. Saline infusion sonography and office hysteroscopy to assess endometrial morbidity associated with tamoxifen intake. Gynecol Oncol 2002, 86:323-329.
12. Polin S.A., Ascher S.M. The effect of tamoxifen on the genital tract. Cancer Imaging 2008, 8:135-145.
13. Achiron R., Lipitz S., Sivan E., Goldenberg M., Mashiach S. Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium. J Ultrasound Med 1995, 14:685-688.
14. Le Donne M., Lentini M., De Meo L., Benedetto V., Mesiti M. Uterine pathologies in patients undergoing tamoxifen therapy for breast cancer: ultrasonographic, hysteroscopic and histological findings. Eur J Gynaecol Oncol 2005, 26:623-626.
15. Dibi R.P., Zettler C.G., Pessini S.A., Ayub A.V., de Almeida S.B., da Silveira G.P. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer. Menopause 2009, 16:293-300.
16. Pérez-Medina T., Bajo J., Huertas M.A., Rubio A. Predicting atypia inside endometrial polyps. J Ultrasound Med 2002, 21:125-128.
17. Mc Gurgan P., Taylor L.J., Duffy S.R., O'Donovan P.J. Does tamoxifen therapy affect the hormone receptor expression and cell proliferation indices of endometrial polyps? An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to tamoxifen. Maturitas 2006, 54:252-259.
18. Mbatsogo B.A., Le Bouëdec G., Michy T., Bourdel N., Fouilloux G., Dauplat J. Endometrial cancers arising in polyps associated with tamoxifen use. Gynecol Obstet Fertil 2005, 33:975-979.